Back to VA Vanguard Capital Management LLC
CRVS
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Corvus Pharmaceuticals, Inc.
Yes. Vanguard Capital Management holds 3,292,710 shares of CRVS (Corvus Pharmaceuticals), worth $49.2M, as of its Q2 2026 13F filing. It increased the position by 58,172 shares (+1.8%) from Q1 2026. Vanguard Capital Management has held CRVS in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$49.2M
Current Shares
3.3M
Total Value Change
+$1.9M
Total Shares Change
+58,172
Quarter-by-Quarter History
Other major holders of CRVS: BlackRock, Inc., State Street Corp., T. Rowe Price Associates, Inc.